Henry Schein, Inc. HSIC
86.37
0.84
0.98%
as of 25 Sep
- Market cap
- $9.5B
- P/E
- 25.0×
Follow HSIC
Indexes
indicate stock being part of an index,
Insider Buys
alert about insiders buying in the last 12 month
Henry Schein, Inc. (HSIC) Book value per share
Henry Schein, Inc.'s book value per share at the end of fiscal 2025 was 32.3×, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was 33.6×. Over the past ten years it has ranged from 17.3× (fiscal 2016) to 32.8× (fiscal 2023); the current reading is higher than 91% of that period. Henry Schein, Inc. ranks 1st of 11 Medical Distribution companies by book value per share.
Book value per share, annual
Annual
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 32.3× | 1.51% |
| FY2024 | 31.8× | (3.18%) |
| FY2023 | 32.8× | 9.10% |
| FY2022 | 30.1× | 3.77% |
| FY2021 | 29.0× | 3.73% |
| FY2020 | 28.0× | 13.85% |
| FY2019 | 24.6× | 5.85% |
| FY2018 | 23.2× | 28.79% |
| FY2017 | 18.0× | 3.96% |
| FY2016 | 17.3× | (0.55%) |
Quarterly
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 33.6× | (1.32%) |
| Mar 2026 | 34.1× | 5.65% |
| Dec 2025 | 32.3× | (3.57%) |
| Sep 2025 | 33.5× | (0.18%) |
| 42 more quarters | Free account |
Against its own ten years
Low 17.3×
High 32.8×
Ten-year median
28.0×
Current reading's percentile
91
Book value per share against peers
| Company | Book value per share |
|---|---|
| HSIC Henry Schein, Inc. | 33.6× |
| COR Cencora, Inc. compare | 16.8× |
| COSM Cosmos Health Inc. compare | 0.3× |
| AHG Akso Health Group Sponsored ADR compare | 0.0× |
| FOCL FocalTherics compare | −0.1× |
| ACH Accendra Health, Inc. compare | −7.2× |
| CAH Cardinal Health, Inc. compare | −11.5× |
| YI 111, Inc. Sponsored ADR compare | −12.5× |
| MCK McKesson Corporation compare | −32.6× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on HSIC
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- The full statement